| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $-0.03 | - | - |
| Q1'26 | $-0.08 | $-0.02 | +75.5% |
| Q4'25 | $-0.09 | $-0.07 | +25.7% |
| Q3'25 | $-0.10 | $-0.03 | +71.3% |
| Q2'25 | $-0.11 | $-0.13 | -17.9% |
| Q1'25 | $-0.12 | $-0.12 | +0.5% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $230M | - | - |
| Q1'26 | $193M | $200M | +3.6% |
| Q4'25 | $182M | $180M | -1.3% |
| Q3'25 | - | $155M | - |
| Q2'25 | - | $144M | - |
| Q1'25 | - | $123M | - |
Market Data
RKLB is currently trading at $146.99, giving Rocket Lab USA Inc. a market cap of 82.89B. Today's range spans $137.91–$156.20, with shares opening at $149.72 and moving up $3.70 (2.6%) from the prior close. DailyIQ's technical score sits at 95/100 (BUY) with a news sentiment reading of 75/100.
Over the past year RKLB has traded between $24.67 and $146.00 - the current price is +495.8% off the 52-week low and +0.7% from the high. 29 analysts cover the stock with a Buy consensus and a mean 12-month target of $103.91 (range $60.00–$150.00), implying downside of -29.3%.
RKLB is scoring 95/100 technically (BUY) and sits at $146.99 - near 52-week highs in its $24.67–$146.00 annual range. Sentiment at 75/100 is bullish. At 82.89B in Industrials market cap, this is the tier where earnings revision cycles have the most impact on price: upward revisions in a large-cap company with bullish momentum tend to attract analyst upgrades, which in turn attract new institutional mandates.
What makes RKLB's BUY setup (95/100) particularly actionable at 82.89B in Industrials capitalization is the scale-to-move ratio: large enough to feature on institutional mandates but not so large that the percentage upside is already compressed by index inertia. At $146.99 (near 52-week highs in $24.67–$146.00), with sentiment running bullish at 75/100, the setup rewards conviction-sized positioning more than it does speculative small bets.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).